First decide whether the roll in your hand really counts as a medical tape
After several years of testing adhesive tapes, the most common cause of rework we see is not a test item that went wrong. It is a standard that was picked wrongly at the very start. The names that appear in registration files vary enormously: medical adhesive tape, breathable tape, non-woven tape, catheter securement strip, wound fixation strip, transparent film dressing. A one-word difference in the product name can send the testing route somewhere completely different, and by the time you find out, the samples and the schedule are already spent.
The decision does not hinge on the name. It hinges on two things: construction and claims.
Look at the construction. If the product is a sandwich of backing, pressure-sensitive adhesive layer and release liner, and its function is to hold something else against the skin, then it is a tape in its own right and the YY/T 0148 route is essentially unavoidable. If an absorbent pad is laminated into the middle of the backing and the adhesive sits only around the perimeter, the product is positioned much closer to a dressing; the main route shifts towards the YY/T 0471 family and the adhesive performance of the border becomes a supporting item rather than the headline.
Look at the claims. As soon as wording such as "for covering wounds", "absorbs exudate" or "promotes healing" appears, the centre of gravity of the evaluation moves from mechanical fixation to wound-contact performance. Add antimicrobial, drug-loaded or silver-containing claims on top of that and you are outside the framework used for an ordinary tape; the route has to be agreed separately and a tape report will not stand in for it.
Look at how it is supplied. If the product is supplied sterile, the packaging system and sterilisation residues have to be planned in at the same time. If it is non-sterile that part drops out, but the drift of adhesive performance across shelf life still does not.
The table below is the triage table we actually use when a job is booked in:
| Product form | Typical functional claim | Main testing route | Item most often forgotten |
|---|---|---|---|
| Plain tape roll (backing plus adhesive) | Securing dressings, securing catheters | YY/T 0148 physical and in-use performance | Biological evaluation for skin contact |
| Composite strip with absorbent pad | Covering wounds, absorbing exudate | Wound-contact performance in the direction of the YY/T 0471 family | Adhesion and residue of the adhesive border |
| Sterile-supplied fixation strip | Post-operative fixation, securing puncture sites | Physical performance plus sterility-related evaluation | Packaging system validation under the ISO 11607 family |
| Long-wear securement tape | Continuous fixation over an indwelling period | Physical performance plus a higher biological tier once contact duration increases | Drift of adhesion after ageing |
| Strip with antimicrobial or drug-loading claims | Antimicrobial, drug delivery | Outside the plain-tape framework; route agreed case by case | Additional evidence of effectiveness and safety |
Get the triage right and everything downstream runs smoothly. Get it wrong and however well the later work is done, it is wasted effort.
Group the YY/T 0148 items by failure mechanism and they are easier to hold in your head
The standard lists items one by one, but when you are planning a submission it is easier to spot what you have missed if you group them by mechanism. Internally we use four groups.
Appearance and dimensional consistency. Whether the backing is damaged, whether the adhesive coating is even, whether there is uncoated area or streaking, whether the end face of the roll is neat, whether the size and labelling match. This group looks the least technical, yet it accounts for a high share of rejected submissions, especially on products whose slitting process is not stable, where the edges tend to carry adhesive crumbs or burrs.
Adhesion. This is the core of a tape. It covers initial tack, the ability to hold under sustained load, and the force recorded when the tape is peeled from the specified test surface. The three items probe different faces of the same adhesive system: tack reflects how well the adhesive wets a surface in a very short contact time, holding power reflects the cohesive strength of the adhesive mass under continuous shear, and peel reflects the combined outcome of wetting and cohesion plus the contribution of the backing. They do not move in the same direction. Softening the adhesive improves tack but usually degrades holding power at the same time, which is the classic see-saw on the formulation side.
Backing and bulk physical properties. Tensile behaviour, extensibility at break, air or moisture-vapour permeability. Permeability matters particularly in medical use: during long wear, the ability of the backing to pass water vapour bears directly on local maceration and the skin reactions that follow.
Usability and residue. Whether the tape unwinds smoothly, whether adhesive is left behind on removal, whether removal delaminates the backing, whether the edges of a stored roll ooze adhesive. These items do not always carry heavy weight in the standard, but they account for a large share of clinical complaints.
The actual test conditions, test-surface materials, loading arrangements and acceptance limits are governed by the current valid version of the standard text. This article deals only with mechanisms and common mistakes, and does not restate parameters.
An engineering look at why peel force does not repeat between runs
This section is a mechanistic analysis based on the load path and material behaviour. It is not a statistical conclusion, and should be read as analysis.
During peeling, the force actually goes to three places: separation of the interface between the adhesive layer and the test surface; the viscoelastic work dissipated as the adhesive mass in the peel zone is stretched, oriented and finally torn; and the elastic and plastic work dissipated as the backing is bent through the peel angle. The number you record is the sum of those three energy sinks divided by the peel width, not a direct read-out of "how sticky the adhesive is".
Once that is clear, the usual sources of poor reproducibility are easy to explain.
The contribution of the backing gets ignored. The same adhesive coated onto backings of different elastic modulus gives a different bend radius in the peel zone, and therefore different bending work. The spread between non-woven, PE and paper backings is often larger than the spread between adhesive formulations. Comparing peel force across products with different backings is therefore not a valid comparison in the first place.
Randomness in the lay-down step. A pressure-sensitive adhesive has to creep into the microscopic roughness of the test surface, and how far it gets depends on the force, the time and the uniformity of the lay-down. The difference between pressing by hand and using a specified roller is frequently larger than the difference produced by a formulation tweak. This is also the most common reason why the same batch of samples splits into layers when different operators run it.
The state of the test surface. Surface energy, roughness, cleanliness and residual wiping solvent on the test panel all change interfacial wetting. A panel that has been used many times and has not been cleaned by the specified procedure will read systematically low.
Dwell time after application. Wetting continues after the tape is applied, so peel force climbs for a period. If dwell time is not standardised, the data will not line up.
Temperature and humidity. The adhesive is a viscoelastic material, and ambient temperature and humidity change its modulus and relaxation time directly. An uncontrolled laboratory environment is equivalent to adding a different offset to every data point.
The fix is not complicated: write the lay-down method, the dwell time, the test-surface cleaning procedure and the environmental conditions into your internal work instruction, and align them with the laboratory. When a job is booked in we normally ask how those four are handled, because once that is on record there is something to trace back to if a dispute arises later. If you want to settle these prerequisites in advance, start with the testing requirements page.
There is one more traceability gap that is routinely overlooked: the peel result should be recorded together with the failure mode. The same force value may sit behind interfacial peel, cohesive failure within the adhesive, tearing of the backing, or a large area of adhesive left on the test surface, and those failure modes mean entirely different things in engineering terms. If only the number is reported and not the mode, then when a repeat run disagrees there is simply no way to tell whether the adhesive system has drifted, the coating is uneven, or it is purely an operator difference. Writing "record the failure mode" into the test request costs almost nothing and saves a great deal of argument later. By the same logic, when comparing batches you should first confirm that the failure modes match. If the modes differ, the force values were never comparable.
Biological evaluation: contact type sets the route, contact duration sets the depth
A medical tape sits in a fairly clear position within the biological evaluation framework: skin contact, a surface-contacting device. The route follows the framework of the ISO 10993 family and the GB/T 16886 family. First classify the device by contact type and contact duration, then plan the evaluation on the basis of that classification and the material information, using existing data where it is available and only generating new testing where the gaps cannot be closed.
For a tape, skin irritation and sensitisation are the two lines you rarely escape. These endpoints are covered by different parts of the ISO 10993 family, and in practice ISO 10993-10 and ISO 10993-23 come into play. One warning belongs here: which endpoint is assigned to which part, and how far the scope of that part extends, must be confirmed against the current valid version of the standard text and against your own evaluation route. Do not simply copy an item list of unknown provenance into a purchase order. For domestic registration the current valid national standard version applies, so confirm the scope of the relevant part of the GB/T 16886 family with the laboratory before placing the order. The effort spent on that step is far smaller than the cost of discovering after testing that the wrong part was chosen and the whole block has to be rescheduled.
Two further points cause more trouble in practice.
First, the contact-duration category tends to jump upwards. Many companies plan on the basis of single use and short-term contact, but the product actually claims continuous fixation throughout an indwelling period, which puts cumulative contact into a longer band and raises the required depth of evaluation. This mismatch is raised often enough during technical review, and adding tests afterwards means extra scheduling. Cumulative contact time must be calculated for the worst-case use scenario: if the instructions for use permit continuous wear, or permit re-application at the same site after removal, those have to be counted in rather than reporting the nominal wear time of a single piece.
Second, a change of adhesive system requires re-evaluation. Change the adhesive supplier, the tackifying resin or the release agent and, even if the physical properties measure much the same, the leachables profile may well have changed. Biological evaluation addresses materials and processes, not force values. For how to approach changes of this kind, see the item descriptions on the biocompatibility testing page.
One more thing deserves its own mention because it is so often confused. Irritation and sensitisation are two independent endpoints. Neither substitutes for the other, and the result of one cannot be used to infer the other. When clinical feedback reports redness at the application site, companies often file it straight under "sensitisation", whereas the more common cause is an irritation response, or in many cases something purely physical: local maceration caused by inadequate breathability of the backing, or mechanical injury caused by a poor removal angle. Attribute it wrongly and the direction of the reformulation goes wrong with it. To locate the cause properly you have to look at the permeability behaviour, the removal-force behaviour and the biological results together. No single report is enough on its own.
Ageing, packaging and shelf life: tape performance drifts
There is a fundamental difference between a tape and a rigid device: the critical performance of a tape comes from a viscoelastic layer that changes over time. Oxidation, plasticiser migration, exudation of tackifying resin and ageing of the backing itself all cause adhesion to drift across the shelf life, and the drift is not necessarily downwards. Plenty of products become tackier with storage and start leaving residue on removal.
Two suggestions for designing the stability programme.
Do not enrol only the sterile barrier. When validating the packaging system of a sterile-supplied product everyone remembers the ISO 11607 family (which part of that family specifies which requirements, and which edition applies, is governed by the current valid version of the standard text), but it is easy to watch only seal integrity and forget to bring adhesion, appearance and residue into the shelf-life study as functional items. If all you have proven at the end point is that the package did not fail, you have no evidence that the product still works, and that gets questioned during review.
Set aside samples for real-time ageing. Using accelerated ageing to buy time is reasonable, but real-time samples must be reserved from the same batch. The ageing mechanism of an adhesive system does not necessarily match the assumptions behind an accelerated model, and real-time data is the backstop. For programme design, see the service descriptions for shelf life and stability and packaging validation.
Sort these out before you ship samples and you save most of the back-and-forth
| Common reason for rejection or retest | Root cause | How to avoid it before submission |
|---|---|---|
| Doubt over which standard applies | Construction and claims do not match | Submit a construction drawing and the full claim text, and confirm the triage first |
| Not enough sample | Quantity estimated from item count only, retests and retains ignored | Reserve for item count, replicates and retains together |
| Roll already opened, edges contaminated | Poor transport and repackaging | Keep the original packaging; label any opened sample separately |
| Sterilisation method of a sterile product not stated | Missing documentation | State the sterilisation method, the batch, and whether sterilisation is complete |
| Peel data does not agree between runs | Lay-down and dwell conditions never agreed | Agree the pre-conditioning in writing and require the failure mode to be recorded |
| Scope of biological evaluation does not match | Contact-duration category set too low | Re-categorise against the actual indwelling claim |
| No re-evaluation after a change | The change was treated as equivalent | Provide a before-and-after comparison of materials and process |
Besides the samples themselves, it is worth supplying the following with the shipment: a cross-section sketch of the construction (backing material, adhesive type, coating method), the full product claims and a draft of the instructions for use, a raw-material list with supplier information, a description of the sterilisation and packaging methods, and any historical data you already hold in house. Historical data is particularly useful. When the laboratory result and your own in-house result disagree, historical data is what lets you decide quickly whether the difference comes from method or from batch.
About SUNGO Lab
SUNGO Lab (Shanghai Shage Medical Technology Co., Ltd.) operates laboratories in Shanghai and Hefei and is accredited by CNAS, CMA and IAS (USA). It should be stated clearly that an accreditation mark only demonstrates that the laboratory holds the corresponding technical competence within its accredited scope; it does not constitute a commitment as to the outcome of market access in any target market. The registration or submission outcome remains subject to the review of the relevant regulatory authority in each country.
For medical tapes and related dressing products we can take on the up-front triage of standard applicability, physical and in-use performance testing, biocompatibility evaluation planning and testing, packaging system validation and shelf-life programme design. We can also get involved before the design is frozen and help you draw up the verification list for formulation and process changes in advance, so that tests do not have to be added under time pressure during registration. If you are still unsure which route your product should take, bring the construction drawing and the claim text and let us talk it through. You can also review the full scope on our services page.
To discuss a project, scheduling or pricing, call +86 132 4819 8029 or request a quote.